within Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EB06_Neostigmine;

model Neostigmine
  extends Pharmacolibrary.Drugs.ATC.S.S01EB06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01EB06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Neostigmine is a reversible acetylcholinesterase inhibitor used to treat myasthenia gravis, reverse the effects of non-depolarizing muscle relaxants after surgery, and manage postoperative ileus and urinary retention. It is a well-established drug and remains in clinical use today, especially in anesthesiology.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult healthy volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Berkó, S, et al., &amp; Gáspár, R (2016). Electroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administration. <i>Drug design, development and therapy</i> 10 1695–1701. DOI:<a href=\"https://doi.org/10.2147/DDDT.S102959\">10.2147/DDDT.S102959</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27274203/\">https://pubmed.ncbi.nlm.nih.gov/27274203</a></p></li><li><p>Hurh, E, et al., &amp; Lee, MG (2000). Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats. <i>Research communications in molecular pathology and pharmacology</i> 108(3-4) 261–273. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11913717/\">https://pubmed.ncbi.nlm.nih.gov/11913717</a></p></li><li><p>Calvey, TN, et al., &amp; Chan, K (1979). Pharmacokinetics and pharmacological effects of neostigmine in man. <i>British journal of clinical pharmacology</i> 7(2) 149–155. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1979.tb00915.x\">10.1111/j.1365-2125.1979.tb00915.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/216382/\">https://pubmed.ncbi.nlm.nih.gov/216382</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Neostigmine;
